{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/108554"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/108554","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"The bioactive role of omega-3 endocannabinoid epoxide regioisomers","abstract":"Omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), possess anti-inflammatory properties and are a source for bioactive lipid metabolites. Dietary EPA and DHA are converted to omega-3 endocannabinoids (eCBs), eicosapentaenoicethanolamide (EPEA) and docosahexaenoicethanolamide (DHEA), respectively. Subsequently, omega-3 eCBs are substrates for eicosanoid-synthesizing enzymes, cyclooxygenase, lipoxygenase and cytochrome P450 (CYP450) to generate novel oxygenated lipid mediators. Recently, CYP450 2J2 (CYP2J2) was found to metabolize EPEA to epoxyeicosatetraenoic-ethanolamide (EEQ-EAs) and DHEA to epoxydocosapentaenoic-ethanolamide (EDP-EAs) that are known as omega-3 eCB epoxides. Previously, 17,18-EEQ-EA and 19,20-EDP-EA have shown to have anti-neuroinflammatory, vasodilatory, anti-angiogenic properties, activate cannabinoid receptors and regulate platelet aggregation in vitro. Although these metabolites have demonstrated beneficial results, very few studies have investigated the biological and pharmacological action of the additional regioisomers such as EPEA epoxides, 14,15-EEQ-EA, 11,12-EEQ-EA, 8,9-EEQ-EA and DHEA epoxides, 16,17-EDP-EA, 13,14-EDP-EA, 10,11-EDP-EA and 7,8-EDP-EA. Hence, this dissertation reports the bioactive role of omega-3 eCB epoxide regioisomers generated by CYP450s regarding their anti-inflammatory properties and activation of cannabinoid receptors. We investigated the differential effect of the distinct omega-3 eCB epoxide regioisomers on cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) activation as well as neuroinflammation in BV-2 microglial cells. Our studies indicate that these eCB epoxides activate cannabinoid receptors with distinct receptor selectivity. They also show anti-inflammatory action by reducing nitrite production in lipopolysaccharide (LPS) stimulated BV-2 microglial cells in the presence and absence of soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) inhibitors. Furthermore, we showed that two specific regioisomers 8,9-EEQ-EA and 13,14-EDP-EA, dose dependently reduced nitrite production and reduced levels of interleukin-6 (IL-6) in LPS stimulated BV-2 microglial cells. Lastly, we demonstrated that 8,9-EEQ-EA and 13,14-EDP-EA altered microglial phenotype by reducing proinflammatory mRNA levels of IL-6, inducible nitric oxide synthase (iNOS), tumour necrosis factor α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) as well as increasing anti-inflammatory mRNA levels of arginase-1 (Arg-1) in LPS stimulated BV-2 microglia. Collectively, we showed that omega-3 eCB epoxide regioisomers differentially activate cannabinoid receptors and are anti-neuroinflammatory in microglial cell culture models.","abstract_html":"Omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), possess anti-inflammatory properties and are a source for bioactive lipid metabolites. Dietary EPA and DHA are converted to omega-3 endocannabinoids (eCBs), eicosapentaenoicethanolamide (EPEA) and docosahexaenoicethanolamide (DHEA), respectively. Subsequently, omega-3 eCBs are substrates for eicosanoid-synthesizing enzymes, cyclooxygenase, lipoxygenase and cytochrome P450 (CYP450) to generate novel oxygenated lipid mediators. Recently, CYP450 2J2 (CYP2J2) was found to metabolize EPEA to epoxyeicosatetraenoic-ethanolamide (EEQ-EAs) and DHEA to epoxydocosapentaenoic-ethanolamide (EDP-EAs) that are known as omega-3 eCB epoxides. Previously, 17,18-EEQ-EA and 19,20-EDP-EA have shown to have anti-neuroinflammatory, vasodilatory, anti-angiogenic properties, activate cannabinoid receptors and regulate platelet aggregation in vitro. Although these metabolites have demonstrated beneficial results, very few studies have investigated the biological and pharmacological action of the additional regioisomers such as EPEA epoxides, 14,15-EEQ-EA, 11,12-EEQ-EA, 8,9-EEQ-EA and DHEA epoxides, 16,17-EDP-EA, 13,14-EDP-EA, 10,11-EDP-EA and 7,8-EDP-EA. Hence, this dissertation reports the bioactive role of omega-3 eCB epoxide regioisomers generated by CYP450s regarding their anti-inflammatory properties and activation of cannabinoid receptors. We investigated the differential effect of the distinct omega-3 eCB epoxide regioisomers on cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) activation as well as neuroinflammation in BV-2 microglial cells. Our studies indicate that these eCB epoxides activate cannabinoid receptors with distinct receptor selectivity. They also show anti-inflammatory action by reducing nitrite production in lipopolysaccharide (LPS) stimulated BV-2 microglial cells in the presence and absence of soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) inhibitors. Furthermore, we showed that two specific regioisomers 8,9-EEQ-EA and 13,14-EDP-EA, dose dependently reduced nitrite production and reduced levels of interleukin-6 (IL-6) in LPS stimulated BV-2 microglial cells. Lastly, we demonstrated that 8,9-EEQ-EA and 13,14-EDP-EA altered microglial phenotype by reducing proinflammatory mRNA levels of IL-6, inducible nitric oxide synthase (iNOS), tumour necrosis factor α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) as well as increasing anti-inflammatory mRNA levels of arginase-1 (Arg-1) in LPS stimulated BV-2 microglia. Collectively, we showed that omega-3 eCB epoxide regioisomers differentially activate cannabinoid receptors and are anti-neuroinflammatory in microglial cell culture models.","abstract_has_math":false,"creators":["Lauderdale, Josephine Enales"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["Nair, Satish","Gennis, Robert B","Huang, Raven H","Fratti, Rutilio A"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-10-07T22:07:08Z","date_published":"2020-10-07T22:07:08Z","updated_at":"2026-07-22T22:24:48Z","subjects":["inflammation","omega-3 fatty acids","cannabinoid receptors","endocannabinoids"],"languages":["en"],"rights":["Copyright 2020 Josephine Lauderdale"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/108554","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Nair, Satish","Gennis, Robert B","Huang, Raven H","Fratti, Rutilio A"]},{"key":"dc:creator","label":"Author","values":["Lauderdale, Josephine Enales"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-10-07T22:07:08Z","2022-10-07T22:44:53Z","2020-06-11","2020-08"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["inflammation","omega-3 fatty acids","cannabinoid receptors","endocannabinoids"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2020 Josephine Lauderdale"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/108554"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), possess anti-inflammatory properties and are a source for bioactive lipid metabolites. Dietary EPA and DHA are converted to omega-3 endocannabinoids (eCBs), eicosapentaenoicethanolamide (EPEA) and docosahexaenoicethanolamide (DHEA), respectively. Subsequently, omega-3 eCBs are substrates for eicosanoid-synthesizing enzymes, cyclooxygenase, lipoxygenase and cytochrome P450 (CYP450) to generate novel oxygenated lipid mediators. Recently, CYP450 2J2 (CYP2J2) was found to metabolize EPEA to epoxyeicosatetraenoic-ethanolamide (EEQ-EAs) and DHEA to epoxydocosapentaenoic-ethanolamide (EDP-EAs) that are known as omega-3 eCB epoxides. Previously, 17,18-EEQ-EA and 19,20-EDP-EA have shown to have anti-neuroinflammatory, vasodilatory, anti-angiogenic properties, activate cannabinoid receptors and regulate platelet aggregation in vitro. Although these metabolites have demonstrated beneficial results, very few studies have investigated the biological and pharmacological action of the additional regioisomers such as EPEA epoxides, 14,15-EEQ-EA, 11,12-EEQ-EA, 8,9-EEQ-EA and DHEA epoxides, 16,17-EDP-EA, 13,14-EDP-EA, 10,11-EDP-EA and 7,8-EDP-EA. Hence, this dissertation reports the bioactive role of omega-3 eCB epoxide regioisomers generated by CYP450s regarding their anti-inflammatory properties and activation of cannabinoid receptors. We investigated the differential effect of the distinct omega-3 eCB epoxide regioisomers on cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) activation as well as neuroinflammation in BV-2 microglial cells. Our studies indicate that these eCB epoxides activate cannabinoid receptors with distinct receptor selectivity. They also show anti-inflammatory action by reducing nitrite production in lipopolysaccharide (LPS) stimulated BV-2 microglial cells in the presence and absence of soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) inhibitors. Furthermore, we showed that two specific regioisomers 8,9-EEQ-EA and 13,14-EDP-EA, dose dependently reduced nitrite production and reduced levels of interleukin-6 (IL-6) in LPS stimulated BV-2 microglial cells. Lastly, we demonstrated that 8,9-EEQ-EA and 13,14-EDP-EA altered microglial phenotype by reducing proinflammatory mRNA levels of IL-6, inducible nitric oxide synthase (iNOS), tumour necrosis factor α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) as well as increasing anti-inflammatory mRNA levels of arginase-1 (Arg-1) in LPS stimulated BV-2 microglia. Collectively, we showed that omega-3 eCB epoxide regioisomers differentially activate cannabinoid receptors and are anti-neuroinflammatory in microglial cell culture models.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2022-08-01","The student, Josephine Lauderdale, accepted the attached license on 2020-06-05 at 13:31.","The student, Josephine Lauderdale, submitted this Dissertation for approval on 2020-06-05 at 13:32.","This Dissertation was approved for publication on 2020-06-11 at 10:32.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14927 on 2020-10-02 at 15:30:35","Made available in DSpace on 2020-10-07T22:07:08Z (GMT). No. of bitstreams: 3 LAUDERDALE-DISSERTATION-2020.pdf: 3855764 bytes, checksum: dd2ded3f5fe3d45481a0c65e28eefcfa (MD5) 06052020_Copyright material_permission.docx: 25792 bytes, checksum: fdaa85b98dda83cc1c159e741dc66483 (MD5) LICENSE.txt: 4217 bytes, checksum: a859de2db97413e738ac4e92a3aba377 (MD5) Previous issue date: 2020-06-11","Embargo set by: Seth Robbins for item 116180 Lift date: 2022-10-07T22:07:19Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 116180 Lift date: 2022-10-07T22:44:53Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["The bioactive role of omega-3 endocannabinoid epoxide regioisomers"]}]}],"canonical_facts":{"dc:contributor":["Nair, Satish","Gennis, Robert B","Huang, Raven H","Fratti, Rutilio A"],"dc:creator":["Lauderdale, Josephine Enales"],"dc:date":["2020-10-07T22:07:08Z","2022-10-07T22:44:53Z","2020-06-11","2020-08"],"dc:description":["Omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), possess anti-inflammatory properties and are a source for bioactive lipid metabolites. Dietary EPA and DHA are converted to omega-3 endocannabinoids (eCBs), eicosapentaenoicethanolamide (EPEA) and docosahexaenoicethanolamide (DHEA), respectively. Subsequently, omega-3 eCBs are substrates for eicosanoid-synthesizing enzymes, cyclooxygenase, lipoxygenase and cytochrome P450 (CYP450) to generate novel oxygenated lipid mediators. Recently, CYP450 2J2 (CYP2J2) was found to metabolize EPEA to epoxyeicosatetraenoic-ethanolamide (EEQ-EAs) and DHEA to epoxydocosapentaenoic-ethanolamide (EDP-EAs) that are known as omega-3 eCB epoxides. Previously, 17,18-EEQ-EA and 19,20-EDP-EA have shown to have anti-neuroinflammatory, vasodilatory, anti-angiogenic properties, activate cannabinoid receptors and regulate platelet aggregation in vitro. Although these metabolites have demonstrated beneficial results, very few studies have investigated the biological and pharmacological action of the additional regioisomers such as EPEA epoxides, 14,15-EEQ-EA, 11,12-EEQ-EA, 8,9-EEQ-EA and DHEA epoxides, 16,17-EDP-EA, 13,14-EDP-EA, 10,11-EDP-EA and 7,8-EDP-EA. Hence, this dissertation reports the bioactive role of omega-3 eCB epoxide regioisomers generated by CYP450s regarding their anti-inflammatory properties and activation of cannabinoid receptors. We investigated the differential effect of the distinct omega-3 eCB epoxide regioisomers on cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) activation as well as neuroinflammation in BV-2 microglial cells. Our studies indicate that these eCB epoxides activate cannabinoid receptors with distinct receptor selectivity. They also show anti-inflammatory action by reducing nitrite production in lipopolysaccharide (LPS) stimulated BV-2 microglial cells in the presence and absence of soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) inhibitors. Furthermore, we showed that two specific regioisomers 8,9-EEQ-EA and 13,14-EDP-EA, dose dependently reduced nitrite production and reduced levels of interleukin-6 (IL-6) in LPS stimulated BV-2 microglial cells. Lastly, we demonstrated that 8,9-EEQ-EA and 13,14-EDP-EA altered microglial phenotype by reducing proinflammatory mRNA levels of IL-6, inducible nitric oxide synthase (iNOS), tumour necrosis factor α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) as well as increasing anti-inflammatory mRNA levels of arginase-1 (Arg-1) in LPS stimulated BV-2 microglia. Collectively, we showed that omega-3 eCB epoxide regioisomers differentially activate cannabinoid receptors and are anti-neuroinflammatory in microglial cell culture models.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2022-08-01","The student, Josephine Lauderdale, accepted the attached license on 2020-06-05 at 13:31.","The student, Josephine Lauderdale, submitted this Dissertation for approval on 2020-06-05 at 13:32.","This Dissertation was approved for publication on 2020-06-11 at 10:32.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14927 on 2020-10-02 at 15:30:35","Made available in DSpace on 2020-10-07T22:07:08Z (GMT). No. of bitstreams: 3 LAUDERDALE-DISSERTATION-2020.pdf: 3855764 bytes, checksum: dd2ded3f5fe3d45481a0c65e28eefcfa (MD5) 06052020_Copyright material_permission.docx: 25792 bytes, checksum: fdaa85b98dda83cc1c159e741dc66483 (MD5) LICENSE.txt: 4217 bytes, checksum: a859de2db97413e738ac4e92a3aba377 (MD5) Previous issue date: 2020-06-11","Embargo set by: Seth Robbins for item 116180 Lift date: 2022-10-07T22:07:19Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 116180 Lift date: 2022-10-07T22:44:53Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/108554"],"dc:language":["en"],"dc:rights":["Copyright 2020 Josephine Lauderdale"],"dc:subject":["inflammation","omega-3 fatty acids","cannabinoid receptors","endocannabinoids"],"dc:title":["The bioactive role of omega-3 endocannabinoid epoxide regioisomers"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:48Z"}